French Consumer Durables Stock News

ENXTPA:ABVX
ENXTPA:ABVXBiotechs

Is Abivax (ENXTPA:ABVX) Quietly Reframing Its Ulcerative Colitis Strategy Around Obefazimod’s Phase 3 Pathway?

Abivax has outlined its 2026 corporate outlook, emphasizing obefazimod’s potential in ulcerative colitis after the December 2025 ABTECT Phase 3 DSMB meeting reported no new safety signals and over 80% patient completion of the 44‑week maintenance trial. An interesting takeaway is the company’s plan to leverage these Phase 3 data to pursue a US regulatory filing for obefazimod later in 2026, underscoring its ambitions in the ulcerative colitis treatment market. Next, we’ll examine how the...
ENXTPA:FGR
ENXTPA:FGRConstruction

European Dividend Stocks Eiffage And 2 More Top Picks

As the European market continues to thrive, with the STOXX Europe 600 Index hitting new highs and closing 2025 with its strongest annual performance since 2021, investors are increasingly looking towards dividend stocks for stable returns amidst an improving economic backdrop. In this environment, a good dividend stock is often characterized by a consistent payout history and solid fundamentals that can withstand varying market conditions.
ENXTPA:ML
ENXTPA:MLAuto Components

European Dividend Stocks To Consider In January 2026

As the European markets continue to show strength, with the STOXX Europe 600 Index reaching new highs and closing out 2025 with a robust annual return, investors are increasingly turning their attention to dividend stocks as a means of capitalizing on this positive economic backdrop. In such an environment, selecting dividend stocks that not only offer attractive yields but also demonstrate stability and growth potential can be an effective strategy for income-focused investors looking to...